Related Experiment Video
Updated: May 22, 2025

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Translation and Validation of the Medication Understanding and Use Self-Efficacy Scale Among Patients With Type 2
Yen-Ming Huang1,2,3, Yu-Meng Yang1, Tzu Wang2
1Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei City, Taiwan.
Objective:
The study aimed to translate and assess the validity and reliability of the Traditional Chinese version of the Medication Understanding and Use Self-Efficacy Scale (MUSE-TC) among patients with type 2 diabetes (T2D) in Taiwan.
Methods:
The original 8-item MUSE was translated into Traditional Chinese using a forward and backward translation method. The translations were reviewed by four experts in pharmacy practice and educational psychology. The validity and reliability of the MUSE-TC were assessed in a cross-sectional study among adults with T2D who were taking diabetes medications. Participants were recruited from five community pharmacies in Taiwan between June 2023 and May 2024. Internal consistency of the MUSE-TC was measured using McDonald's omega (ω), while construct validity was evaluated through confirmatory factor analysis. Criterion validity was established by examining the relationship between self-efficacy and medication adherence.
Results:
A total of 274 patients participated in the study. Confirmatory factor analysis identified a two-factor structure for the 8-item MUSE-TC, consisting of the "taking medication" and "learning about medication" domains. All items loaded onto their intended factors, with factor loadings ranging from 0.433 to 0.511. The scale demonstrated excellent internal consistency, with McDonald's ω values of 0.914 for the "taking medication" domain and 0.906 for the "learning about medication" domain. These robust psychometric properties were further supported by criterion validity, as self-efficacy was shown to be associated with medication adherence. Specifically, the "taking medication" domain was positively correlated with fewer barriers to medication-taking (r = 0.382, p < 0.001), suggesting that individuals with higher self-efficacy tend to adhere to their prescribed medication regimen.
Conclusions:
This study presents the MUSE-TC with psychometrically sound properties that will enable healthcare professionals to prospectively assess self-efficacy in medication use and evaluate the impact of self-efficacy on a variety of health outcomes across patients with different chronic diseases.
Patient Or Public Contribution:
Patients, pharmacists, pharmacy staff, and academic experts worked together on the translation and validation of this self-efficacy scale for medication adherence among individuals with chronic illnesses. Community engagement played a key role in translating the scale, recruiting participants, collecting data, conducting analysis, and interpreting the findings. These collaborative efforts ensure the study relevance and applicability to patient care in routine healthcare settings.
More Related Videos
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

